Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-002024-21Phase 3Completed
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Primary safety endpoint. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-002024-21.